Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study.
Drysdale M, Galimov ER, Yarwood MJ, Patel V, Levick B, Gibbons DC, Watkins JD, Young S, Pierce BF, Lloyd EJ, Kerr W, Birch HJ, Kamalati T, Brett SJ. Drysdale M, et al. Among authors: patel v. BMJ Open Respir Res. 2024 Apr 4;11(1):e002238. doi: 10.1136/bmjresp-2023-002238. BMJ Open Respir Res. 2024. PMID: 38575338 Free PMC article.
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C).
Bell CF, Bobbili P, Desai R, Gibbons DC, Drysdale M, DerSarkissian M, Patel V, Birch HJ, Lloyd EJ, Zhang A, Duh MS; N3C consortium. Bell CF, et al. Among authors: patel v. Clin Drug Investig. 2024 Mar;44(3):183-198. doi: 10.1007/s40261-024-01344-4. Epub 2024 Feb 20. Clin Drug Investig. 2024. PMID: 38379107 Free PMC article.
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study.
Patel V, Yarwood MJ, Levick B, Gibbons DC, Drysdale M, Kerr W, Watkins JD, Young S, Pierce BF, Lloyd EJ, Birch HJ, Kamalati T, Brett SJ. Patel V, et al. Curr Med Res Opin. 2024 Aug;40(8):1323-1334. doi: 10.1080/03007995.2024.2376144. Epub 2024 Jul 8. Curr Med Res Opin. 2024. PMID: 38975862
Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records.
Bell CF, Gibbons DC, Drysdale M, Birch HJ, Lloyd EJ, Patel V, Carpenter C, Carlson K, Calay ES, Puranik A, Wagner TE, O'Horo JC, Razonable RR. Bell CF, et al. Among authors: patel v. PLoS One. 2024 Jul 16;19(7):e0304822. doi: 10.1371/journal.pone.0304822. eCollection 2024. PLoS One. 2024. PMID: 39012863 Free PMC article.
Comparison of three source attribution methods applied to whole genome sequencing data of monophasic and biphasic Salmonella Typhimurium isolates from the British Isles and Denmark.
Guzinski J, Arnold M, Whiteley T, Tang Y, Patel V, Trew J, Litrup E, Hald T, Smith RP, Petrovska L. Guzinski J, et al. Among authors: patel v. Front Microbiol. 2024 Nov 14;15:1393824. doi: 10.3389/fmicb.2024.1393824. eCollection 2024. Front Microbiol. 2024. PMID: 39611092 Free PMC article.
Examining Brain Structures and Cognitive Functions in Patients with Recovered COVID-19 Infection: A Multicenter Study Using 7T MRI.
Liou JJ, Santini T, Li J, Gireud-Goss M, Patel V, Adeyemi OF, de Erausquin GA, Garbarino VR, Habes M, Himali JJ, Karmonik C, Snitz BE, Mettenburg JM, Wu M, Aizenstein HJ, Marsland AL, Gianaros PJ, Bowtell R, Mougin O, Vahidy FS, Girard TD, Jacobs HIL, Hosseini AA, Seshadri S, Ibrahim TS. Liou JJ, et al. Among authors: patel v. medRxiv [Preprint]. 2024 Nov 15:2024.11.13.24317121. doi: 10.1101/2024.11.13.24317121. medRxiv. 2024. PMID: 39606361 Free PMC article. Preprint.
6,116 results